GCG and cancer: Our observed neutral or cancer-protective associations between endogenous incretin levels and incident first cancer should be viewed in the light of the fact that associations between endogenous levels of incretins and incident first cancer were explored here, whereas incretin-based drug usage results in supraphysiological incretin levels.